ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
Benzinga
SEPTEMBER 16, 2024
We continue to expect the transaction to create substantial shareholder value and generate high single-digit to low double-digit accretion in 2025 adjusted non-GAAP EPS with substantially higher accretion thereafter." 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. .'
Let's personalize your content